Global Infusion Therapy Market
size was valued at USD 29.7 billion in
2025 and is expected to reach at USD 54.6 billion in 2033, with a CAGR of 6.4% during the forecast
period of 2025 to 2033.
Global Infusion Therapy Market Overview
The global infusion therapy
market encompasses the delivery of fluids, medications, and nutrients directly
into the bloodstream through intravenous or other parenteral routes. It plays a
vital role in treating chronic and acute conditions such as cancer, diabetes,
gastrointestinal disorders, and immune deficiencies. Market growth is driven by
the rising burden of chronic diseases, an aging population, and increased use
of biologics and specialty drugs. Technological advancements in infusion
devices, along with the expanding adoption of home and ambulatory infusion
services, are further enhancing treatment efficiency, patient comfort, and
overall healthcare outcomes worldwide.
Global Infusion Therapy Market Scope
|
Global Infusion
Therapy Market |
|||
|
Years
Considered |
|||
|
Historical Period |
2020 - 2024 |
Market Size (2025) |
USD 29.7 Billion |
|
Base Year |
2025 |
Market Size
(2033) |
USD 54.6 Billion |
|
Forecast Period |
2026 - 2033 |
CAGR (2026 – 2033) |
6.4% |
|
Segments
Covered |
|||
|
By Product |
·
Infusion Pumps o Volumetric
Pumps o Syringe
Pumps o Patient-Controlled
Analgesia (PCA) Pumps o Ambulatory/Portable
Pumps o Enteral
Feeding Pumps ·
Infusion Consumables & Accessories o IV
Sets o IV
Catheters & Cannulas o Needleless
Connectors o Administration
Sets |
||
|
By Indicator |
·
Cancer ·
Gastrointestinal
Diseases/Disorders ·
Congestive
Heart Failure ·
Rheumatoid
Arthritis ·
Hemophilia ·
Immune
Deficiencies ·
Others |
||
|
By Therapy |
·
Antibiotic/Antiviral ·
Anti-coagulation ·
Anti-emetics ·
Blood Component Stimulating Factor ·
Chemotherapy ·
Nutrition ·
Hydration ·
Pain Management |
||
|
By Application |
·
Chemotherapy ·
Diabetes ·
Gastrointestinal
Diseases ·
Pain
Management ·
Others |
||
|
By End User |
·
Hospitals ·
Ambulatory Surgical Centers ·
Clinics ·
Homecare Settings |
||
|
Countries
Catered |
|||
|
North America |
·
United States ·
Canada ·
Mexico |
||
|
Europe |
·
United
Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest
of Europe |
||
|
Asia Pacific |
·
China ·
India ·
Japan ·
Australia ·
South Korea ·
Rest of Asia Pacific |
||
|
Latin America |
·
Brazil ·
Argentina ·
Rest
of Latin America |
||
|
Middle East & Africa
|
·
Saudi Arabia ·
South Africa ·
Rest of MEA |
||
|
Key Companies |
|||
Global Infusion Therapy Market Dynamics
The global infusion therapy
market dynamics are shaped by a combination of clinical demand, technological
innovation, and evolving healthcare delivery models. A major driver is the
increasing prevalence of chronic and life-threatening diseases such as cancer,
autoimmune disorders, diabetes, and cardiovascular conditions, which often
require long-term and precise drug administration through infusion therapy. The
growing geriatric population further accelerates demand, as older patients
typically require continuous and supportive infusion-based treatments. In
parallel, the rapid adoption of biologics, biosimilars, and specialty
drugs—many of which cannot be administered orally—has significantly expanded
the application scope of infusion therapy across therapeutic areas.
Technological advancements play a
critical role in market expansion, with the development of smart infusion
pumps, dose error reduction systems, and improved vascular access devices
enhancing patient safety and treatment accuracy. Additionally, healthcare
systems worldwide are increasingly shifting from hospital-based infusion toward
home and ambulatory infusion settings to reduce costs and improve patient
convenience. However, the market also faces restraints such as high treatment
and device costs, risk of infusion-related complications, and stringent
regulatory requirements governing infusion devices and drug administration.
Limited access to skilled healthcare professionals, particularly in emerging
economies, further challenges market growth.
Despite these constraints,
opportunities continue to emerge through digital health integration, remote
patient monitoring, and expanding healthcare infrastructure in developing
regions. Overall, the interplay between rising clinical demand, innovation, cost
pressures, and regulatory oversight defines the competitive and evolving
landscape of the global infusion therapy market.
Global Infusion Therapy Market
Segment Analysis
The global infusion therapy
market segment analysis highlights a diverse and well-structured landscape
driven by product innovation, expanding clinical applications, and evolving
care settings. By product, infusion pumps represent a significant share of the
market due to their critical role in accurate and controlled drug delivery.
Volumetric pumps are widely used in hospitals for continuous fluid
administration, while syringe pumps are preferred for low-volume and
high-precision drug delivery, particularly in neonatal and critical care.
Patient-controlled analgesia (PCA) pumps support effective pain management by
allowing patients to self-administer controlled doses, whereas ambulatory or
portable pumps are gaining traction with the growth of home infusion therapy.
Enteral feeding pumps are increasingly utilized for long-term nutritional
support. Infusion consumables and accessories, including IV sets, IV catheters
and cannulas, needleless connectors, and administration sets, form a recurring
revenue segment due to their high usage rates and single-use nature.
By indication, cancer remains a
dominant segment owing to the extensive use of chemotherapy, immunotherapy, and
supportive infusion treatments. Gastrointestinal diseases, congestive heart
failure, rheumatoid arthritis, hemophilia, and immune deficiencies also
contribute significantly, supported by the need for long-term and targeted
infusion therapies. In terms of therapy type, chemotherapy and antibiotic or
antiviral infusion therapies account for substantial demand, followed by
nutrition, hydration, pain management, anti-coagulation, anti-emetics, and
blood component stimulating factors, reflecting the broad therapeutic utility
of infusion therapy.
By application, chemotherapy
leads the market due to the rising global cancer burden, while diabetes,
gastrointestinal diseases, and pain management applications continue to expand
with improved infusion technologies. Other applications include critical care
and supportive therapies. By end user, hospitals hold the largest market share
due to advanced infrastructure and high patient inflow. However, ambulatory
surgical centers, clinics, and homecare settings are witnessing rapid growth,
driven by cost-efficiency, patient convenience, and the increasing shift toward
decentralized healthcare delivery models.
Global Infusion Therapy Market
Regional Analysis
The global infusion therapy
market exhibits varied growth patterns across regions, influenced by healthcare
infrastructure, disease prevalence, and adoption of advanced medical
technologies. North America dominates the market due to its well-established healthcare
system, high prevalence of chronic diseases, strong reimbursement frameworks,
and early adoption of advanced infusion devices and home infusion services.
Europe follows closely, supported by an aging population, increasing cancer
incidence, and favorable government initiatives promoting patient safety and
quality care. The Asia Pacific region is expected to witness the fastest
growth, driven by rising healthcare expenditure, expanding hospital networks,
growing awareness of infusion-based treatments, and a large patient pool in
countries such as China and India. Latin America shows steady growth owing to
improving healthcare infrastructure and increasing access to advanced
therapies. Meanwhile, the Middle East and Africa market is gradually expanding,
supported by healthcare investments, although growth remains constrained by
limited access to skilled professionals and advanced infusion technologies.
Global Infusion Therapy Market Key Players
·
Option Care Health Inc.
·
Baxter International Inc.
·
ICU Medical, Inc.
·
B. Braun Melsungen AG
·
Terumo Corporation
·
Moog Inc.
·
Fresenius SE & Co. KGaA
·
Smiths Medical
·
JMS Co. Ltd.
·
CareFusion Corporation
Recent Developments
In May 2025, KabaFusion,
a U.S. home and alternative site infusion therapy provider, acquired Infusion
Care assets from Coram®, adding six infusion pharmacies and ambulatory suites
and significantly expanding its reach across 26 states to serve more patients
with chronic and acute therapies.
In January 2026, The
National Home Infusion Association (NHIA) welcomed Inovalon to its Future
of Infusion Advisory Council, a collaboration aimed at using data analytics and
technology to address operational and clinical workflow challenges in home and
alternate site infusion care.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
The global infusion therapy market was valued at approximately USD 29.7 billion in 2025 and is projected to grow significantly over the forecast period, reaching over USD 54 billion by 2033, driven by rising demand for advanced therapeutic delivery solutions.
